NCT06220864 2026-04-14SNV1521 in Participants With Advanced Solid TumorsSynnovation Therapeutics, Inc.Phase 1 Recruiting400 enrolled
NCT03150056 2022-08-10Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerGlaxoSmithKlinePhase 1 Terminated73 enrolled 34 charts